Bacitracin
Bacitracin is a pharmaceutical drug with 9 clinical trials. Historical success rate of 66.7%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
44.4%
4 of 9 finished
55.6%
5 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown
Comparison of Collagenase With Antibiotic Ointment of Minor Partial Thickness Burns
A Comparison of the Outcomes of Distal Fingertip Amputations Treated With Either Artificial (Xeroform) or Biological Dressings
Bacterial Biofilms in Reconstructive Breast Prostheses Following Mastectomy
The Relationship of Hemoglobin A1c and Diabetic Wound Healing
Clinical Trials (9)
The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown
Comparison of Collagenase With Antibiotic Ointment of Minor Partial Thickness Burns
A Comparison of the Outcomes of Distal Fingertip Amputations Treated With Either Artificial (Xeroform) or Biological Dressings
Bacterial Biofilms in Reconstructive Breast Prostheses Following Mastectomy
The Relationship of Hemoglobin A1c and Diabetic Wound Healing
Comparison of Wound Bed Establishment in Facial Burns
Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge
Using Santyl or Bacitracin on Second Degree Burns
Pilot Study To Evaluate A Pharmacologically Active Nasal Sponge Following Endoscopic Sinus Surgery
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9